AI Is Revolutionizing Biotech. Can Regulation Keep Up?

Scientists have used artificial intelligence to design novel, viable viruses, a breakthrough celebrated as a major advance against antibiotic resistance but raising urgent regulatory concerns, according to The Conversation.

The recent announcement of novel, viable viruses https://theconversation.com/scientists-have-designed-a-functioning-virus-from-scratch-using-ai-what-you-need-to-know-289319 created by artificial intelligence AI was celebrated as a major advance in the fight against antibiotic resistance https://www.sciencedirect.com/science/article/pii/S0163725826001191 . But it also raised urgent concerns about regulation. The recent announcement of novel, viable viruses https://theconversation.com/scientists-have-designed-a-functioning-virus-from-scratch-using-ai-what-you-need-to-know-289319 created by artificial intelligence AI was celebrated as a major advance in the fight against antibiotic resistance https://www.sciencedirect.com/science/article/pii/S0163725826001191 . But it also raised urgent concerns about regulation.